We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Gyroscopic Radiosurgery Platform Ablates Brain Tumors

By HospiMedica International staff writers
Posted on 11 Feb 2019
A novel radiotherapy (RT) platform delivers high-dose stereotactic radiosurgery (SRS) to non-invasively ablate brain tumors and other select intracranial conditions.

The ZAP Surgical Systems (San Carlos, CA, USA) ZAP-X Gyroscopic Radiosurgery system is a self-contained, self-shielded therapeutic RT device dedicated to the treatment of benign and malignant intracranial and cervical spine lesions, in some cases as inferior as C7. More...
ZAP-X is powered by a 2.7 megavolt S-band linear accelerator (LINAC) which serves as the source of the therapeutic radiation, mounted within a combination of yoked gimbals, each of which accurately rotates around the common isocenter, much like a large gyroscope.

Accurate beam positioning is accomplished by the LINAC beam crossfiring from 2π steradians of solid angle, and precise movements of the robotic patient table. Most components needed to produce the beam, such as the radiofrequency power source, waveguide system, and beam triggering electronics, as well as significant radiation shielding, are mounted on or integrated into the rotating patient treatment chamber sphere. The patient is supported on the moveable treatment table, which extends outside the treatment sphere, but which itself is also enclosed by additional radiation shielding during SRS.

The Zap-X accomplishes precise three-dimensional (3D) patient registration by means of an integrated planar kilovolt (kV) imaging system that also rotates around the patient’s head. Pairs of non-coaxial x-ray images and image-to-image correlations are used to determine the location of the patient’s anatomy in relation to the machine isocenter, both prior to and during SRS treatment. A fully integrated dosimetry validation system monitors and verifies delivered RT dosage in real-time. Finally, ZAP-X incorporates a unique self-shielded design that typically eliminates the need for costly radiation vaults.

“After almost a decade of effort, we're incredibly proud of what the ZAP-X can mean to cancer patients,” said professor of neurosurgery John Adler, MD, CEO of ZAP Surgical Systems. “Using leading-edge technology, we've removed many historical limitations to the wider availability of SRS, and in doing so, seek to establish a new standard in precision radiation medicine.”

SRS is a non-surgical radiation therapy used to treat functional abnormalities and small tumors of the brain. When SRS is used to treat body tumors, it is called stereotactic body radiotherapy (SBRT). Both SRS and SBRT are an image-guided radiation therapy (IGRT), relying on 3D imaging and localization techniques, immobilization systems for precise patient position during therapy, and highly focused gamma ray or x-ray beams that converge on the tumor.

Related Links:
ZAP Surgical Systems


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Tourniquet System
heidi– mein Tourniquet
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.